Six-month success of radiofrequency ablation in cardiac arrhythmias treatment – experience of our centre

Ružica  Jurčević Mudrić; Lazar  Angelkov; Milosav Tomović; Dejan Kojić; Predrag  Milojević

doi:10.2298/VSP170125109J

Ružica Jurčević Mudrić Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia
Lazar Angelkov Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia
Milosav Tomović Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia
Dejan Kojić Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia
Predrag Milojević Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP170125109J

Keywords: arrhythmias, cardiac;, catheter ablation;, electrocardiography;, recurrence;, serbia.

Abstract

Background/Aim. Numerous trials have shown a high success of radiofrequency ablation (RFA) in the treatment of the patients with cardiac arrhythmias. We aimed to examine the RFA initial success in treatment of different cardiac arrhythmias and the RFA success after 6 months of follow-up. Second aim was to evaluate influence of all clinical and echocardiography parameters on initial and 6-month success and failure of RFA. Methods. The present study included 320 consecutive patients with atrial and ventricular arrhythmias in which RFA was performed during 2014 in the Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia. We evaluated the initial RFA success and success of this procedure after 6-month follow-up. We also investigated the prognostic role of clinical and echocardiography parameters on initial and 6-month success and failure of RFA. Results. The RFA initial success for RFA of atrioventriculas (AV) node and AV nodal reentrant tachycardia (AVNRT) was 100%, RFA of pulmonary veins 99%, RFA of atrial flutter 92%, RFA of premature ventricular complexes (PVC) and the Wolf-Parkinson-White (WPW) syndrome 87%, RFA of ventricular tachycardia 85% and RFA of atrial tachycardia 78%. The success of RFA after 6 months of follow-up for RFA of the AV node was 100%, RFA of AVNRT 94%, RFA of atrial flutter 90%, RFA of WPW syndrome 86%, RFA of pulmonary veins 79% (paroxysmal atrial fibrillation 88% and persistent atrial fibrillation 63% with a significant difference p < 0.05), RFA of PVC 78%, RFA of ventricular tachycardia 77% and RFA of atrial tachycardia 67%. Conclusion. This study proved a very high RFA initial success in treatment of cardiac arrhythmias and a satisfactory RFA success after 6 months of follow-up. Only the prognostic value had the type of atrial fibrillation in the group with catheter ablated pulmonary veins: after 6-month follow-up, the patients with paroxysmal atrial fibrillation had a significantly better outcome than those with persistent form.

Author Biography

Ružica Jurčević Mudrić, Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia

Magistar Kardiologije

Subspecijalista Kardiologije

Odsek za elektrofiziologiju i elektrostimulaciju

References

R E F E R E N C E S

Pederson TC, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dick¬feld T, et al. EHRA/HRS/APHRS expert consensus of ven¬tricular arrhythmias. Europace 2014; 16(9): 1257–83.

Mann D, Zipes D, Libby P, Bonow R. Braunwald's Heart Dis-ease: A Textbook of Cardiovascular Medicine, Single Volume. 10th ed. Philadelphia, PA, USA: Saunders Elsevier; 2014.

Tung R, Boyle NG, Shivkumar K. Catheter ablation of ventricu-lar tachycardia. Circulation 2010; 122(3): e389–91.

Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fib-rillation: Llessons from a 5-year follow-up. Circulation 2010; 122(23): 2368–77.

Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. J Am Coll Cardiol 2008; 51(8): 779–86.

Zipes PD, Jalife J. Cardiac electrophysiology. From cell to Bed-side. 4th ed. Philadelphia, Pa: W.B. Saunders; 2004.

Sohns C, Sohns JM, Bergau L, Sossalla S, Vollmann D, Lüthje L, et al. Pulmonary vein anatomy predicts freedom from atrial fib¬rillation using remote magnetic navigation for circumferen-tial pulmonary vein ablation. Europace 2013; 15(8): 1136–42.

Calkins H, Kuck KH, Cappato R, Brugada J, Camm JA, Chen S, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Rec-om¬mendations for patient selection, procedural techniques, pa¬tient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14(4): 528–606.

Stern JD, Rolnitzky L, Goldberg JD, Chinitz LA, Holmes DS, Bern¬stein NE, et al. Meta-analysis to assess the appropriate end¬point for slow pathway ablation of atrioventricular nodal re¬entrant tachycardia. Pacing Clin Electrophysiol 2011; 34(3): 269–77.

Olgun H, Yokokawa M, Baman T, Kim HM, Armstrong W, Good E, et al. The role of interpolation in PVC-induced cardio-myopathy. Heart Rhythm 2011; 8(7): 1046–9.

Hall MC, Todd DM. Modern management of arrhythmias. Post¬grad Med J 2006; 82(964): 117–25.

d'Avila A, Koruth JS, Dukkipati S, Reddy VY. Epicardial access for the treatment of cardiac arrhythmias. Europace 2012; 14 Suppl 2: ii13–ii18.

Wei W, Zhan X, Xue Y, Fang X, Liao H, Deng H, et al. Fea-tures of accessory pathways in adult Ebstein's anomaly. Euro-pace 2014; 16(11): 1619–25.

Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: Final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999; 99(2): 262–70.